Volumen 52 #3 | Año 2015 Volver Indice
resumen Resumen abstract Abstract pdf PDF
  GH Receptor Polymorphisms in Acromegalic Patients  
  Authors: Céspedes ME  
  The growth hormone receptor mediates the effects of GH. Several isoforms of this receptor, as a product of polymorphisms in the coding sequences of GHR gene, have been identified. The d3-GHR isoform lacks a 22-amino-acid sequence encoded by exon 3, and although its ligand binding capacity remains intact, its deletion would affect the functional properties of GHR, and could facilitate the activation of the GHR. It has been reported that 50 % of acromegalic patients have at least one d3 allele.
The d3 allele has been shown to contribute to predict postoperative response presenting significantly lower levels of GH in contrast to fl-GHR (full-length), with similar levels of IGF-1. The absence of exon 3 was also associated with abgreater likelihood of failing to achieve normal IGF-I after both surgical and medical treatment. In carriers of d3-GHR, lower doses of PEG (Pegvisomant) were required; the mechanism of this increased sensitivity is unknown.These patients may also have a higher prevalence of acromegalic comorbidities.
These studies demonstrate the importance of the GHR genotype, which may not only contribute to predict clinical outcome, but also help to identify the optimal therapy for each patient.

Rev Argent Endocrinol Metab 52:163-169, 2015
No conflicts of interest exist.
  Key words: acromegaly, receptor of growth hormone, GHR polymorphisms, isoforms of GHR  
  Díaz Vélez 3889 (C1200AAF)
Ciudad Autónoma de Bs. As. (ARG)
  Tel. +54 011 4983-9800 - Interno 3 
  RAEM está indizada en:
  Chemical Abstracts, 
EMBASE / Excerpta Medica, 
LILACS,  Latindex,  SIIC Data Bases 
SciELO Argentina